Q32 Bio (QTTB) Cash from Investing Activities Growth (3y) (2020 - 2025)
Q32 Bio (QTTB) Cash from Investing Activities Growth (3y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
116.52% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
38.24% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Q32 Bio |
167.59 Mn |
116.84 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-27.00% |
| Dec 31, 2024 |
-25.99% |
| Sep 30, 2024 |
30.01% |
| Jun 30, 2024 |
39.59% |
| Mar 31, 2024 |
26.02% |
| Sep 30, 2023 |
-25.99% |
| Jun 30, 2023 |
-97.32% |
| Mar 31, 2023 |
-25.99% |
| Dec 31, 2022 |
42.58% |
| Sep 30, 2022 |
-101.96% |
| Jun 30, 2022 |
-2.60% |
| Mar 31, 2022 |
104.55% |
| Dec 31, 2021 |
62.36% |
| Sep 30, 2021 |
28.06% |
| Jun 30, 2021 |
47.21% |
| Mar 31, 2021 |
-145.72% |
| Dec 31, 2020 |
77.14% |
| Sep 30, 2020 |
408.75% |
| Jun 30, 2020 |
381.87% |
| Mar 31, 2020 |
416.19% |
